Top analysts on stock perps · Analyst
Andrea Newkirk (Goldman Sachs): analyst track record on stock perps
Andrea Newkirk of Goldman Sachs on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars
0.6★
Success
36%
Excess return
-8.6%
rank
#11,104
Ratings
25
Ratings on stock perps
29
Track record
TipRanks data| 12 months | 3 years | |
|---|---|---|
| Ratings | 34 | 52 |
| Stock | 17 | 21 |
| Buy / hold / sell | 15 / 12 / 7 | 25 / 19 / 8 |
| Upgrades / downgrades / initiations | 0 / 0 / 17 | 0 / 1 / 20 |
| Price targets hit / missed | 10 / 23 (30%) | 20 / 28 (42%) |
| Avg. return after a rating (TipRanks) | +15.2% | +41.4% |
| Best / worst call | +438.7% / -48.2% | +708.0% / -48.2% |
After buy calls: not enough measured cases yet
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $ABCL AbCellera Biologics Inc. | Hold · Maintained | $14.00 | +16.0% | Nov 9, 2026 |
| $INSM Insmed Incorporated | Buy · Maintained | $194 | +66.5% | Oct 30, 2026 |
| $KOD Kodiak Sciences Inc. | Hold · Maintained | $103 | -4.7% | Sep 29, 2026 |
| $ARWR Arrowhead Pharmaceuticals, Inc. | Hold · Initiated | $74.00 | +50.3% | Sep 24, 2026 |
| $IOVA Iovance Biotherapeutics, Inc. | Buy · Initiated | $15.00 | +85.6% | Sep 24, 2026 |
| $RVMD Revolution Medicines, Inc. | Buy · Initiated | $267 | +39.5% | Sep 24, 2026 |
Recent ratings
- Nov 9, 2026$ABCL: Maintained · Hold · $14.00Read the rating ↗
- Oct 30, 2026$INSM: Maintained · Buy · $194Read the rating ↗
- Sep 29, 2026$KOD: Maintained · Hold · $103Read the rating ↗
- Sep 24, 2026$KOD: Initiated · HoldRead the rating ↗
- Sep 24, 2026$ABCL: Initiated · Hold · $13.00Read the rating ↗
- Sep 24, 2026$ARWR: Initiated · Hold · $74.00Read the rating ↗
- Sep 24, 2026$INSM: Initiated · Buy · $188Read the rating ↗
- Sep 24, 2026$RVMD: Initiated · Buy · $267Read the rating ↗
- Sep 24, 2026$IOVA: Initiated · Buy · $15.00Read the rating ↗
- Feb 11, 2026$INSM: Reiterated · Buy · $230Read the rating ↗
- Feb 5, 2026$IOVA: Maintained · Sell · $2.00Read the rating ↗
- Jan 7, 2026$ARWR: Maintained · Hold · $85.00Read the rating ↗
- Dec 18, 2025$INSM: Maintained · Buy · $225Read the rating ↗
- Dec 4, 2025$INSM: Maintained · Buy · $225Read the rating ↗
- Nov 20, 2025$ARWR: Maintained · Hold · $48.00Read the rating ↗
- Nov 10, 2025$IOVA: Maintained · Sell · $1.50Read the rating ↗
- Nov 7, 2025$SDGR: Maintained · Hold · $21.00Read the rating ↗
- Oct 31, 2025$INSM: Maintained · Buy · $225Read the rating ↗
- Oct 3, 2025$INSM: Reiterated · Buy · $196Read the rating ↗
- Sep 29, 2025$SDGR: Initiated · Hold · $19.00Read the rating ↗
Andrea Newkirk0.6★ · 36% success · -8.6% excess return · TipRanks data · Source headlines via TheFly/StreetInsider. Reaction = venue-median perp move after our detection — an observation, not investment advice.